Trial Profile
A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic Syndrome
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Fludarabine (Primary) ; Busulfan; Cyclophosphamide
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms FA5-Bucy
- 06 Dec 2016 Results (n=64) assessing outcomes of Haploidentical hematopoietic stem cell transplantation, presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
- 08 Jan 2015 New trial record